Melatonin Neurim

Melatonin, the active ingredient in Melatonin Neurim, is a melatonin receptor agonist presented as a tablet for oral use. It helps regulate the circadian rhythm and is used to promote sleep onset in adults with insomnia or other sleep‑wake rhythm disturbances.

GNH USA supplies Melatonin Neurim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation for each batch, ensuring reliable access across multiple markets and competitive pricing.

Melatonin Neurim acts on melatonin receptors to address disorders of sleep regulation. - Insomnia: Facilitates sleep onset and improves sleep continuity in adults experiencing difficulty falling asleep. - Delayed sleep phase disorder: Shifts circadian timing to promote earlier sleep onset. - Jet lag: Assists in realigning the internal clock after rapid time‑zone travel.

Adverse reactions to Melatonin Neurim are generally mild, but some users may experience more pronounced effects. Common Side Effects: - Drowsiness: Excessive sleepiness during daytime. - Headache: Mild to moderate head pain. - Nausea: Stomach discomfort or queasiness. Serious or Rare Side Effects: - Allergic reaction: Rash, itching, swelling, or difficulty breathing. - Mood changes: New or worsening depression or anxiety. - Cardiovascular symptoms: Palpitations or irregular heartbeat.

When considering Melatonin Neurim, several precautionary measures should be observed to ensure safe use. - Age limitation: Use in adults unless a healthcare professional advises otherwise. - Concomitant CNS depressants: Avoid combining with sedatives or alcohol, which may increase drowsiness. - Underlying medical conditions: Assess for depression, epilepsy, or autoimmune disorders before use. - Pregnancy and lactation: Discuss potential risks with a physician, as safety data are limited. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Melatonin Neurim can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Benzodiazepines: Combined use may cause excessive sedation. - Anticoagulants: May enhance anticoagulant effect, increasing bleeding risk. Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., cyclosporine): May reduce melatonin metabolism. - Antidepressants (SSRIs, MAOIs): Potential for altered sleep patterns. - Caffeine‑containing products: May counteract melatonin’s sleep‑promoting effect.